Clinical trial
Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B…
NCT00480792 · ANRS, Emerging Infectious Diseases, Other · Completed
Key facts
| NCT number | NCT00480792 |
|---|---|
| Title | Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients |
| Official title | Open-label, Randomized, and Multicentric Phase III Clinical Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV-1-infected Patients With CD4-positive T-lymphocytes Counts Above 200 permm3 ANRS HB 03 VIHVAC-B |
| Acronym | VIHVAC-B |
| Lead sponsor | ANRS, Emerging Infectious Diseases, Other |
| Collaborators | MCM Vaccines B.V. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Biological |
| Interventions | GenHevac B Pasteur |
| Enrollment | 437 |
| Start date | Jun 1, 2007 |
| Primary completion | Dec 1, 2008 |
| Completion | Sep 1, 2012 |
| First posted | May 31, 2007 |
| Last update posted | Jul 23, 2013 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: